Arzeda raises $12M Series A to commercialize cloud platform that designs custom proteins for manufacturing and agriculture
Seattle synthetic-biology startup Arzeda raised $12 million in a Series A led by the OS Fund to commercialize a cloud-based platform that designs custom proteins and metabolic pathways for manufacturing, agriculture and other industries.